Splenomegaly in predicting the survival of patients with advanced primary liver cancer treated with immune checkpoint inhibitors - Concepedia

Concepedia

Publication | Open Access

Splenomegaly in predicting the survival of patients with advanced primary liver cancer treated with immune checkpoint inhibitors

DOI Full Paper Access

31

Citations

20

References

2022

Year

Lushan Xiao, Chengyi Hu, Hao Cui, Rui-ning Li, Chang Hong, Qi-mei Li, Chao‐Yi Huang, Zhong‐Yi Dong, Hongbo Zhu, Li Liu

Cancer Medicine

Abstract

We concluded that splenomegaly was a predictor of prognosis in patients with PLC treated with ICIs. This is the first study to report this important finding.

References

	Year	Citations

Page 1